Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes with Novel Approaches to Targeted Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--
Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes with Novel Approaches to Targeted Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--
Key Studies in Lymphomas and CLL: Independent Conference Coverage of ASH 2022

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Challenging the Current Treatment Paradigm for Patients With Follicular Lymphoma: Recent and Emerging Evidence

Content Format:

Tool

Credit Type:

--

Credits:

--
Current and Emerging Therapeutic Advances in Follicular Lymphoma: A Class in Session

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Current and Emerging Therapeutic Advances in Follicular Lymphoma

Content Format:

Slideset

Credit Type:

--

Credits:

--
2022 ASH Annual Meeting: Expert Discussion of New Agents for Follicular Lymphoma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2022 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
ASCO 2022: Advances in CLL/SLL

Content Format:

Podcast Episodes

Credit Type:

AAPA | ANCC

Credits:

0.50
An Expert’s Guide to ASCO 2022: Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Applying Novel Advances in Relapsed/Refractory Follicular Lymphoma

Content Format:

Interactive Video Lecture

Credit Type:

AAPA | ANCC

Credits:

1.00